Analytical Data
-
Gene name
ESYT2
- Application
-
Alternative Names
(E-Syt2)(Chr2Syt)
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0FGR8
-
Expression Region
191-662aa
-
Molecular Weight
61.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ESYT2, or elongation of very long chain fatty acids protein 2, is a member of the ESYT family involved in the regulation of lipid metabolism and cellular signaling. Its primary role pertains to the transport and synthesis of lipids, particularly in the endoplasmic reticulum and the plasma membrane. Recent studies have highlighted ESYT2's involvement in processes such as membrane biogenesis, lipid droplet formation, and the regulation of cellular fatty acid composition, which are crucial for various physiological functions. Furthermore, dysregulation of ESYT2 has been linked to metabolic disorders, including obesity, diabetes, and cardiovascular diseases. The protein's importance in maintaining cellular homeostasis and its potential implications in disease pathology have made it a target for research aimed at understanding lipid-related disorders and developing therapeutic strategies. Investigating ESYT2 is crucial for elucidating its mechanisms of action and exploring its role in diseases, ultimately contributing to the advancement of novel treatments for metabolic conditions.
